+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Nutrition Market - Growth, Trends, and Forecasts (2023-2028)

  • PDF Icon


  • 115 Pages
  • April 2023
  • Region: Global
  • Mordor Intelligence
  • ID: 4896199
UP TO OFF until Mar 31st 2024
Over the next few years, the oncology nutrition market is expected to grow at an annual rate of 8.9%.

The COVID-19 pandemic turned the spotlight on the oncology nutrition market, though the healthcare systems have been significantly impacted. For instance, the study published by Nutrition and Cancer in May 2021 focused on creating recommendations on the nutritional protocol for the management and prevention of complications during the COVID-19 pandemic for all cancer patients. Patients with cancer are more susceptible to illnesses due to either direct immune system impairment or anticancer medication. Furthermore, as per the article published by the National Library of Medicine in June 2021, the role of nutrition, dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 phase, as well as the value of diet in the susceptibility, prevention, and management of COVID-19 in cancer patients, the COVID-19 pandemic demanded the development of nutritional maintenance and complication control recommendations for all cancer patients, according to the same source. However, the market was gradually stabilizing as COVID-19 cases declined, resulting in the return of normal demand levels for oncology nutrition. Thus, COVID-19 was expected to have a significant impact on the oncology nutrition market over the forecast period.

The major factors contributing to the growth of the oncology nutrition market are the rising prevalence of cancer worldwide and the introduction of new oncology nutrition products. According to a BioMed Central Ltd article published in April 2022, the number of new cancer cases in Germany is expected to rise by 20% by 2030.Additionally, according to the AACR Cancer Progress Report 2022, in the past three years, the number of cancer survivors living in the United States has increased by more than a million, reaching more than 18 million as of January 1, 2022. The use of nutritional products during and after the treatment of cancer gives the ability to fight disease and offers strength and stamina against the treatment’s after-effects, which is driving the market's growth.

Furthermore, the awareness provided by the government and private agencies is one of the main fueling factors for market growth. For instance, as per the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net, after cancer treatment is complete, most experts recommend a healthy diet that includes plenty of fruits, vegetables, and whole grains. Furthermore, according to the Agency for Healthcare Research and Quality, the prevalence of malnutrition among adults with cancer is high in October 2021, with estimates ranging from 25% to 80% across patient populations.This increase in malnutrition among cancer patients is expected to increase the demand for oncology nutrition, thus boosting market growth over the forecast period.

Hence, as per the aforementioned factors, the oncology nutrition market is likely to grow over the forecast period. However, the high cost of premium nutrition products for oncology restrains the market's growth.

Oncology Nutrition Market Trends

Lung Cancer is Expected to Witness a Healthy Growth Over the Forecast Period

The lung cancer segment is likely to grow during the study period owing to factors such as the high prevalence of lung cancer worldwide, an increase in lung cancer nutritional supplements, and raising awareness of the importance of taking nutritional supplements. For instance, as per Lung Cancer Fact 2022, lung cancer is the leading cause of cancer death worldwide. In the United States, an estimated 236,740 people will be diagnosed with lung cancer in 2022.1 in 16 people were diagnosed with lung cancer in their lifetime - 1 in 15 men and 1 in 17 women. As the number of cancer patients rises, since nutrition gives the body the power to fight disease and provides strength and stamina to withstand the side effects of treatment, the need for oncology nutrition is projected to grow over the forecast period.

Furthermore, government initiatives encourage people to consume proper nutrition both during and after cancer treatment.For that purpose, the agencies are relaxing and preparing many regulations relating to the same. For instance, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced the 'Medical Nutrition Therapy Act,' bipartisan legislation that would expand Medicare Part B to cover medical nutrition therapy (MNT) services for additional conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (e.g., celiac disease), cardiovascular disease, HIV/AIDS, and other diseases or conditions that cause unintentional weight loss. Such movements are likely to help people financially and motivate them to be more keen on taking nutritional supplements, thereby boosting the market's growth.

Hence, as per the factors mentioned above, the lung cancer segment is likely to grow in the oncology nutrition market over the forecast period.

North America is Expected to Witness a Healthy Growth Over the Forecast Period

North America is expected to witness growth in the overall oncology nutrition market throughout the forecast period. This is due to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure, among other major factors. For instance, as per the report from the American Cancer Society for 2022, there are estimated to be 1.9 million new cancer cases diagnosed in the United States in 2022. Moreover, government initiatives, product launches, and collaborations in cancer nutrition supplements boost market growth. For instance, the Academy of Nutrition and Dietetics conducted the '2022 Oncology Nutrition Symposium' on June 20, 2022. In the symposium, they discuss the practice of oncology nutrition, which covers research, prevention, treatment, recovery, palliative care, and hospice.

Furthermore, the Canada Cancer Society estimates that there will be 233,900 new cancer cases in Canada in 2022. The increasing incidence of cancer cases in the region of North America is anticipated to boost market growth. Additionally, many certification programs and awareness classes are conducted regionally to educate cancer patients and providers regarding the importance of oncology nutrition. For example, the Oncology Nutrition Institute (ONI) provides evidence-based educational certification and training programs in the field of modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Its flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program for qualified nutrition, health, and medical practitioners. Its flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program for qualified nutrition, health, and medical practitioners. Thus, such an increase in cancer cases is expected to increase the demand for oncology nutrition, eventually driving the market.

Hence, as per the factors mentioned above, North America is expected to witness growth over the forecast period.

Oncology Nutrition Market Competitor Analysis

The oncology nutrition market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well-known, including Abbott Laboratories, Nestle, Fresenius Kabi AG, B. Braun SE, and Hormel Foods Corporation, among others.

Additional benefits of purchasing the report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising prevalence of Cancer Worldwide
4.2.2 Introduction of New Oncology Nutrition Products
4.3 Market Restraints
4.3.1 High Cost of Premium Nutrition Products for Oncology
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Cancer Type
5.1.1 Head & Neck Cancer
5.1.2 Stomach & Gastrointestinal Cancers
5.1.3 Blood Cancer
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Other Cancers
5.2 By End-User
5.2.1 Hospitals
5.2.2 Home Care
5.2.3 Other End-Users
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Nestle
6.1.3 Fresenius Kabi AG
6.1.4 B. Braun SE
6.1.5 Hormel Foods Corporation
6.1.6 Sofina (Danone S.A.)
6.1.7 Meiji Holdings Company, Ltd.
6.1.8 Global Health Products, Inc.
6.1.9 Victus, Inc.
6.1.10 Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Nestle
  • Fresenius Kabi AG
  • B. Braun SE
  • Hormel Foods Corporation
  • Sofina (Danone S.A.)
  • Meiji Holdings Company, Ltd.
  • Global Health Products, Inc.
  • Victus, Inc.
  • Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)